Item 4.01.
|
Change in Registrants Certifying Accountant
|
Effective March 27, 2020, the Board of Directors of Rapid Therapeutic Science Laboratories, Inc. (the "Company"), formerly, Holly Brothers Pictures, Inc., dismissed Prager Metis CPAs LLP (Prager) as the Company's independent registered public accounting firm. The Company's Board of Directors recommended and approved the engagement by the Company of PWR CPA, LLP (PWR) to serve as the Company's independent registered public accounting firm, effective March 27, 2020.
The report of Prager on the financial statements of the Company as of and for the fiscal year ended March 31, 2019, contained no adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope, or accounting principles. Prager was not the Companys independent registered public accounting firm during the year ended March 31, 2018.
During the Company's fiscal year ended March 31, 2019, and the subsequent interim period from April 1, 2019 to the date of this report, there were no disagreements between the Company and Prager on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Prager, would have caused Prager to make reference to the subject matter of such disagreements in connection with its audit reports on the Company's financial statements.
During the Company's fiscal year ended March 31, 2019, and the subsequent interim period from April 1, 2019 to the date of this report, there were no reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K.
During the Company's fiscal years ended March 31, 2019 and 2018, and the subsequent interim period from April 1, 2019 to the date of this report, the Company did not consult with PWR regarding any of the matters set forth in Items 304(a)(2)(i) and (ii) of Regulation S-K.
The Company has provided Prager with a copy of the disclosures in this report and has requested that Prager furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not Prager agrees with the statements in this Item 4.01. A copy of this letter is filed as Exhibit 16.1 to this report.